Can a dietician and fitbit help pancreatic cancer patients feel better during chemo?
NCT ID NCT05675059
First seen Jun 24, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study tests a program called STRONG that gives pancreatic cancer patients extra support from a dietician and a Fitbit to track their food intake. The goal is to see if patients find the program helpful and easy to stick with while they are on chemotherapy. About 80 adults with advanced pancreatic cancer will take part for 16 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dietician consultations and Fitbit food tracking
- What this could lead to
- If successful, this program could provide a practical way to help pancreatic cancer patients maintain better nutrition and weight during chemotherapy.
- What could go wrong
- This is a small, early feasibility study with only 80 participants, so results may not apply to all patients. It focuses on satisfaction and adherence, not on curing the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?
- Can a pill rouse the immune system against pancreatic cancer?